| Date Filed | Type | Description |
| 05/15/2023 |
4
| SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 9,808 shares
@ $0 |
|
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 6,693 shares
@ $0 |
|
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 1,215 shares
@ $0 |
|
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2021 |
4
| SEVERINO MICHAEL (Vice Chairman) has filed a Form 4 on AbbVie Inc.|
Txns:
| Gifted 583 shares
@ $0 |
|
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2020 |
4
| SEVERINO MICHAEL (Vice Chairman) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 90,679 shares
@ $93.61, valued at
$8.5M
|
|
| 04/24/2020 |
4
| SEVERINO MICHAEL (Director) has filed a Form 4 on Avantor, Inc.|
Txns:
| Granted 10,022 shares
@ $0 |
|
| 04/24/2020 |
3
| SEVERINO MICHAEL (Director) has filed a Form 3 on Avantor, Inc. |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2019 |
4
| SEVERINO MICHAEL (Vice Chairman) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 26,710 shares
@ $79.41, valued at
$2.1M
|
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2018 |
4
| SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 20,800 shares
@ $96.9688, valued at
$2M
Sold 29,200 shares
@ $97.9147, valued at
$2.9M
|
|
| 03/02/2018 |
4
| SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 27,683 shares
@ $118.26, valued at
$3.3M
Sold 2,643 shares
@ $117.928, valued at
$311.7k
|
|
| 02/16/2018 |
4
| SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 15,375 shares
@ $0
Granted 17,319 shares
@ $0
Granted 14,991 shares
@ $0
Granted 46,320 options to buy
@ $114.36, valued at
$5.3M
|
|
| 11/13/2017 |
4
| SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 25,633 shares
@ $94.6909, valued at
$2.4M
|
|
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/03/2016 |
4
| SEVERINO MICHAEL (EVP, R&D and CSO) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 21,574 shares
@ $62.83, valued at
$1.4M
|
|